Adagio Therapeutics, Inc. held its Annual Meeting of Stockholders on June 22, 2022, elected Tamsin Berry, Marc Elia and Clive Meanwell as Class I directors, each to serve for a three-year term expiring at the 2025 annual meeting of stockholders and until his or her respective successor has been duly elected and qualified.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.15 USD | +3.86% | -6.52% | -45.43% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-45.43% | 247M | |
-2.31% | 103B | |
+0.56% | 95.71B | |
+1.69% | 22.02B | |
-17.37% | 20.9B | |
-9.30% | 17.85B | |
-41.01% | 16.21B | |
-14.85% | 15.52B | |
+3.21% | 13.86B | |
+33.54% | 12.04B |
- Stock Market
- Equities
- IVVD Stock
- News Invivyd, Inc.
- Adagio Therapeutics, Inc. Elects Class I Directors